A patient’s Psoriasis Area and Severity Index (PASI) is a measure of overall psoriasis severity and coverage. It is a commonly-used measure in clinical trials for psoriasis treatments. Typically, the PASI would be calculated before, during and after a treatment period in order to determine how well psoriasis responds to the treatment under test (a lower PASI means less psoriasis, generally).